A federal jury in Boston convicted two former executives at Acclarent — a unit of Johnson & Johnson — of illegally marketing a medical device, according to The Wall Street Journal.
The jury found William Facteau, former CEO of Acclarent, and Patrick Fabian, the company's past vice president of sales, guilty of 10 counts of misdemeanor for introducing adulterated and misbranded medical devices into interstate commerce.
The jury acquitted the two men of 15 felony counts, including conspiracy and wire fraud.
Mr. Facteau and Mr. Fabian were indicted in April 2015 for attempting to market a sinus-opening device for use that was not approved by the Food and Drug Administration.
They were also accused of conspiracy to commit securities fraud since they did not tell Johnson & Johnson about the alleged activities when the healthcare giant acquired Acclarent for $785 million in 2010.
Mr. Facteau and Mr. Fabian's lawyers both plan to file appeals to overturn the convictions. The maximum sentence for their misdemeanor charges is one year in prison per count.
More articles on supply chain:
India's growing role in the US generic drug market: 5 things to know
Patients expect discounts for soaring drug costs: 3 things to know
Abbott's sales rise over high medical device demand